Retatrutide is a whole new drug being designed by Eli Lilly, the company of Mounjaro and Zepbound. It’s presently staying studied for weight loss and type 2 diabetic issues, with a few similarities to orforglipron, An additional drug designed by Eli Lilly. Some compounding pharmacies publicize retatrutide availability as a result of telehealth